INOVIO PHARMACEUTICALS, INC. Quarterly Debt-to-equity in % from Q1 2012 to Q3 2024

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Inovio Pharmaceuticals, Inc. quarterly Debt-to-equity history and growth rate from Q1 2012 to Q3 2024.
  • Inovio Pharmaceuticals, Inc. Debt-to-equity for the quarter ending September 30, 2024 was 41.6 %, a 2.9% decline year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2024 41.6 -1.24 -2.9% Sep 30, 2024
Q2 2024 40.4 -4.24 -9.51% Jun 30, 2024
Q1 2024 39.8 -8.9 -18.3% Mar 31, 2024
Q4 2023 38.4 -5.72 -13% Dec 31, 2023
Q3 2023 42.8 +6.9 +19.2% Sep 30, 2023
Q2 2023 44.6 +16 +56% Jun 30, 2023
Q1 2023 48.7 +28.2 +138% Mar 31, 2023
Q4 2022 44.1 +26.9 +156% Dec 31, 2022
Q3 2022 35.9 +20.1 +127% Sep 30, 2022
Q2 2022 28.6 +9.98 +53.6% Jun 30, 2022
Q1 2022 20.5 -13.1 -39.1% Mar 31, 2022
Q4 2021 17.2 -34.7 -66.8% Dec 31, 2021
Q3 2021 15.8 -78.8 -83.3% Sep 30, 2021
Q2 2021 18.6 -144 -88.5% Jun 30, 2021
Q1 2021 33.7 -153 -82% Mar 31, 2021
Q4 2020 52 -228 -81.5% Dec 31, 2020
Q3 2020 94.6 -55.4 -36.9% Sep 30, 2020
Q2 2020 162 +69.2 +74.4% Jun 30, 2020
Q1 2020 187 +127 +210% Mar 31, 2020
Q4 2019 280 +237 +550% Dec 31, 2019
Q3 2019 150 +112 +293% Sep 30, 2019
Q2 2019 93.1 +58.3 +167% Jun 30, 2019
Q1 2019 60.2 +26.5 +78.7% Mar 31, 2019
Q4 2018 43.2 +11.5 +36.3% Dec 31, 2018
Q3 2018 38.2 +4.28 +12.6% Sep 30, 2018
Q2 2018 34.9 -1.3 -3.6% Jun 30, 2018
Q1 2018 33.7 -1.1 -3.16% Mar 31, 2018
Q4 2017 31.7 +1.84 +6.17% Dec 31, 2017
Q3 2017 33.9 +8.38 +32.8% Sep 30, 2017
Q2 2017 36.2 +13.8 +61.4% Jun 30, 2017
Q1 2017 34.8 +15.9 +84.1% Mar 31, 2017
Q4 2016 29.8 +12.9 +76.1% Dec 31, 2016
Q3 2016 25.5 +9.76 +61.8% Sep 30, 2016
Q2 2016 22.4 +8.16 +57.3% Jun 30, 2016
Q1 2016 18.9 +2.99 +18.8% Mar 31, 2016
Q4 2015 16.9 +0.19 +1.14% Dec 31, 2015
Q3 2015 15.8 -6.91 -30.5% Sep 30, 2015
Q2 2015 14.3 -14.1 -49.8% Jun 30, 2015
Q1 2015 15.9 -22.7 -58.8% Mar 31, 2015
Q4 2014 16.7 -38 -69.4% Dec 31, 2014
Q3 2014 22.7 -22.8 -50.1% Sep 30, 2014
Q2 2014 28.4 -18.2 -39.1% Jun 30, 2014
Q1 2014 38.6 +0.6 +1.58% Mar 31, 2014
Q4 2013 54.7 +18.6 +51.3% Dec 31, 2013
Q3 2013 45.5 +10.5 +29.9% Sep 30, 2013
Q2 2013 46.6 +16.3 +53.9% Jun 30, 2013
Q1 2013 38 +10.7 +39.1% Mar 31, 2013
Q4 2012 36.1 Dec 31, 2012
Q3 2012 35 Sep 30, 2012
Q2 2012 30.3 Jun 30, 2012
Q1 2012 27.3 Mar 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.